OCT4‐positive circulating tumor cells may predict a poor prognosis in patients with metastatic castration‐resistant prostate cancer treated with abiraterone plus prednisone therapy

ABSTRACT:

SUBMITTER: Ma Y 

PROVIDER: S-EPMC10502952 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature